Loading…
Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?
Alzheimer's disease (AD) is the most common form of dementia. There is limited choice in modern therapeutics, and drugs available have limited success with multiple side effects in addition to high cost. Hence, newer and alternate treatment options are being explored for effective and safer the...
Saved in:
Published in: | Phytotherapy research 2014-04, Vol.28 (4), p.517-525 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783 |
---|---|
cites | cdi_FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783 |
container_end_page | 525 |
container_issue | 4 |
container_start_page | 517 |
container_title | Phytotherapy research |
container_volume | 28 |
creator | Ahmed, Touqeer Gilani, Anwarul‐Hassan |
description | Alzheimer's disease (AD) is the most common form of dementia. There is limited choice in modern therapeutics, and drugs available have limited success with multiple side effects in addition to high cost. Hence, newer and alternate treatment options are being explored for effective and safer therapeutic targets to address AD. Turmeric possesses multiple medicinal uses including treatment for AD. Curcuminoids, a mixture of curcumin, demethoxycurcumin, and bisdemethoxycurcumin, are vital constituents of turmeric. It is generally believed that curcumin is the most important constituent of the curcuminoid mixture that contributes to the pharmacological profile of parent curcuminoid mixture or turmeric. A careful literature study reveals that the other two constituents of the curcuminoid mixture also contribute significantly to the effectiveness of curcuminoids in AD. Therefore, it is emphasized in this review that each component of the curcuminoid mixture plays a distinct role in making curcuminoid mixture useful in AD, and hence, the curcuminoid mixture represents turmeric in its medicinal value better than curcumin alone. The progress in understanding the disease etiology demands a multiple‐site‐targeted therapy, and the curcuminoid mixture of all components, each with different merits, makes this mixture more promising in combating the challenging disease. Copyright © 2013 John Wiley & Sons, Ltd. |
doi_str_mv | 10.1002/ptr.5030 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1544012765</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1513058267</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783</originalsourceid><addsrcrecordid>eNqN0l1rFDEUBuAgit1WwV-gA72oN1NPviYTb0pZbSsUrXar4k3IzJ7Y1JnNmsxQ6683y64rCIJX-XrycsIJIU8oHFIA9mI5xEMJHO6RCQWtSyoVv08moCUtBa0_75DdlG4AQDMQD8kO47XitRQTcjm7xmiXOA6-LS7CgIvB264IrpiNsceYd_2iOO5-XqPPy4NUvPIJbcKXxXSM7djn0xC38-Dn6egReeBsl_DxZtwjVyevZ9Oz8vzd6Zvp8XnZylx1KVAIZEqwigmqrRMNRdfU3Elnq9a1ulFVLbDSXNhGYwtO1LVGyJfnc6dqvkeer3OXMXwfMQ2m96nFrrMLDGMyVAoBlKlK_gelHGTNKpXp_l_0JoxxkR-yUkwyVgH9E9jGkFJEZ5bR9zbeGQpm1ROTe2JWPcn06SZwbHqcb-HvJmRQrsGt7_Dun0HmYvZhE7jxPg34Y-tt_GZy_UqaT29PjTibvv9IhTRfsn-29s4GY79Gn8zVJQMq8odQWinGfwE_q6vy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1512522601</pqid></control><display><type>article</type><title>Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Ahmed, Touqeer ; Gilani, Anwarul‐Hassan</creator><creatorcontrib>Ahmed, Touqeer ; Gilani, Anwarul‐Hassan</creatorcontrib><description>Alzheimer's disease (AD) is the most common form of dementia. There is limited choice in modern therapeutics, and drugs available have limited success with multiple side effects in addition to high cost. Hence, newer and alternate treatment options are being explored for effective and safer therapeutic targets to address AD. Turmeric possesses multiple medicinal uses including treatment for AD. Curcuminoids, a mixture of curcumin, demethoxycurcumin, and bisdemethoxycurcumin, are vital constituents of turmeric. It is generally believed that curcumin is the most important constituent of the curcuminoid mixture that contributes to the pharmacological profile of parent curcuminoid mixture or turmeric. A careful literature study reveals that the other two constituents of the curcuminoid mixture also contribute significantly to the effectiveness of curcuminoids in AD. Therefore, it is emphasized in this review that each component of the curcuminoid mixture plays a distinct role in making curcuminoid mixture useful in AD, and hence, the curcuminoid mixture represents turmeric in its medicinal value better than curcumin alone. The progress in understanding the disease etiology demands a multiple‐site‐targeted therapy, and the curcuminoid mixture of all components, each with different merits, makes this mixture more promising in combating the challenging disease. Copyright © 2013 John Wiley & Sons, Ltd.</description><identifier>ISSN: 0951-418X</identifier><identifier>EISSN: 1099-1573</identifier><identifier>DOI: 10.1002/ptr.5030</identifier><identifier>PMID: 23873854</identifier><identifier>CODEN: PHYREH</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>adverse effects ; Alzheimer disease ; Alzheimer Disease - drug therapy ; Animals ; Curcuma - chemistry ; Curcuma longa ; curcumin ; Curcumin - analogs & derivatives ; Curcumin - pharmacology ; Curcumin - therapeutic use ; curcuminoids ; dementia ; Diarylheptanoids ; drugs ; etiology ; Humans ; Molecular Structure ; Phytotherapy ; synergy ; therapeutics ; therapy ; turmeric</subject><ispartof>Phytotherapy research, 2014-04, Vol.28 (4), p.517-525</ispartof><rights>Copyright © 2013 John Wiley & Sons, Ltd.</rights><rights>Copyright © 2014 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783</citedby><cites>FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23873854$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahmed, Touqeer</creatorcontrib><creatorcontrib>Gilani, Anwarul‐Hassan</creatorcontrib><title>Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?</title><title>Phytotherapy research</title><addtitle>Phytother. Res</addtitle><description>Alzheimer's disease (AD) is the most common form of dementia. There is limited choice in modern therapeutics, and drugs available have limited success with multiple side effects in addition to high cost. Hence, newer and alternate treatment options are being explored for effective and safer therapeutic targets to address AD. Turmeric possesses multiple medicinal uses including treatment for AD. Curcuminoids, a mixture of curcumin, demethoxycurcumin, and bisdemethoxycurcumin, are vital constituents of turmeric. It is generally believed that curcumin is the most important constituent of the curcuminoid mixture that contributes to the pharmacological profile of parent curcuminoid mixture or turmeric. A careful literature study reveals that the other two constituents of the curcuminoid mixture also contribute significantly to the effectiveness of curcuminoids in AD. Therefore, it is emphasized in this review that each component of the curcuminoid mixture plays a distinct role in making curcuminoid mixture useful in AD, and hence, the curcuminoid mixture represents turmeric in its medicinal value better than curcumin alone. The progress in understanding the disease etiology demands a multiple‐site‐targeted therapy, and the curcuminoid mixture of all components, each with different merits, makes this mixture more promising in combating the challenging disease. Copyright © 2013 John Wiley & Sons, Ltd.</description><subject>adverse effects</subject><subject>Alzheimer disease</subject><subject>Alzheimer Disease - drug therapy</subject><subject>Animals</subject><subject>Curcuma - chemistry</subject><subject>Curcuma longa</subject><subject>curcumin</subject><subject>Curcumin - analogs & derivatives</subject><subject>Curcumin - pharmacology</subject><subject>Curcumin - therapeutic use</subject><subject>curcuminoids</subject><subject>dementia</subject><subject>Diarylheptanoids</subject><subject>drugs</subject><subject>etiology</subject><subject>Humans</subject><subject>Molecular Structure</subject><subject>Phytotherapy</subject><subject>synergy</subject><subject>therapeutics</subject><subject>therapy</subject><subject>turmeric</subject><issn>0951-418X</issn><issn>1099-1573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqN0l1rFDEUBuAgit1WwV-gA72oN1NPviYTb0pZbSsUrXar4k3IzJ7Y1JnNmsxQ6683y64rCIJX-XrycsIJIU8oHFIA9mI5xEMJHO6RCQWtSyoVv08moCUtBa0_75DdlG4AQDMQD8kO47XitRQTcjm7xmiXOA6-LS7CgIvB264IrpiNsceYd_2iOO5-XqPPy4NUvPIJbcKXxXSM7djn0xC38-Dn6egReeBsl_DxZtwjVyevZ9Oz8vzd6Zvp8XnZylx1KVAIZEqwigmqrRMNRdfU3Elnq9a1ulFVLbDSXNhGYwtO1LVGyJfnc6dqvkeer3OXMXwfMQ2m96nFrrMLDGMyVAoBlKlK_gelHGTNKpXp_l_0JoxxkR-yUkwyVgH9E9jGkFJEZ5bR9zbeGQpm1ROTe2JWPcn06SZwbHqcb-HvJmRQrsGt7_Dun0HmYvZhE7jxPg34Y-tt_GZy_UqaT29PjTibvv9IhTRfsn-29s4GY79Gn8zVJQMq8odQWinGfwE_q6vy</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Ahmed, Touqeer</creator><creator>Gilani, Anwarul‐Hassan</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>FBQ</scope><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201404</creationdate><title>Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?</title><author>Ahmed, Touqeer ; Gilani, Anwarul‐Hassan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>adverse effects</topic><topic>Alzheimer disease</topic><topic>Alzheimer Disease - drug therapy</topic><topic>Animals</topic><topic>Curcuma - chemistry</topic><topic>Curcuma longa</topic><topic>curcumin</topic><topic>Curcumin - analogs & derivatives</topic><topic>Curcumin - pharmacology</topic><topic>Curcumin - therapeutic use</topic><topic>curcuminoids</topic><topic>dementia</topic><topic>Diarylheptanoids</topic><topic>drugs</topic><topic>etiology</topic><topic>Humans</topic><topic>Molecular Structure</topic><topic>Phytotherapy</topic><topic>synergy</topic><topic>therapeutics</topic><topic>therapy</topic><topic>turmeric</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahmed, Touqeer</creatorcontrib><creatorcontrib>Gilani, Anwarul‐Hassan</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Phytotherapy research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahmed, Touqeer</au><au>Gilani, Anwarul‐Hassan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?</atitle><jtitle>Phytotherapy research</jtitle><addtitle>Phytother. Res</addtitle><date>2014-04</date><risdate>2014</risdate><volume>28</volume><issue>4</issue><spage>517</spage><epage>525</epage><pages>517-525</pages><issn>0951-418X</issn><eissn>1099-1573</eissn><coden>PHYREH</coden><abstract>Alzheimer's disease (AD) is the most common form of dementia. There is limited choice in modern therapeutics, and drugs available have limited success with multiple side effects in addition to high cost. Hence, newer and alternate treatment options are being explored for effective and safer therapeutic targets to address AD. Turmeric possesses multiple medicinal uses including treatment for AD. Curcuminoids, a mixture of curcumin, demethoxycurcumin, and bisdemethoxycurcumin, are vital constituents of turmeric. It is generally believed that curcumin is the most important constituent of the curcuminoid mixture that contributes to the pharmacological profile of parent curcuminoid mixture or turmeric. A careful literature study reveals that the other two constituents of the curcuminoid mixture also contribute significantly to the effectiveness of curcuminoids in AD. Therefore, it is emphasized in this review that each component of the curcuminoid mixture plays a distinct role in making curcuminoid mixture useful in AD, and hence, the curcuminoid mixture represents turmeric in its medicinal value better than curcumin alone. The progress in understanding the disease etiology demands a multiple‐site‐targeted therapy, and the curcuminoid mixture of all components, each with different merits, makes this mixture more promising in combating the challenging disease. Copyright © 2013 John Wiley & Sons, Ltd.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>23873854</pmid><doi>10.1002/ptr.5030</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0951-418X |
ispartof | Phytotherapy research, 2014-04, Vol.28 (4), p.517-525 |
issn | 0951-418X 1099-1573 |
language | eng |
recordid | cdi_proquest_miscellaneous_1544012765 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | adverse effects Alzheimer disease Alzheimer Disease - drug therapy Animals Curcuma - chemistry Curcuma longa curcumin Curcumin - analogs & derivatives Curcumin - pharmacology Curcumin - therapeutic use curcuminoids dementia Diarylheptanoids drugs etiology Humans Molecular Structure Phytotherapy synergy therapeutics therapy turmeric |
title | Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T02%3A39%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20Potential%20of%20Turmeric%20in%20Alzheimer's%20Disease:%20Curcumin%20or%20Curcuminoids?&rft.jtitle=Phytotherapy%20research&rft.au=Ahmed,%20Touqeer&rft.date=2014-04&rft.volume=28&rft.issue=4&rft.spage=517&rft.epage=525&rft.pages=517-525&rft.issn=0951-418X&rft.eissn=1099-1573&rft.coden=PHYREH&rft_id=info:doi/10.1002/ptr.5030&rft_dat=%3Cproquest_cross%3E1513058267%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5100-4e44e274262419af4b1efb83f5fa6cfc9b7684e6934ab9ec0f4889e0510ddf783%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1512522601&rft_id=info:pmid/23873854&rfr_iscdi=true |